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Abstract
BRCA1 controls early steps of the synthesis-dependent strand annealing (SDSA) pathway of
homologous recombination, but has no known role following Rad51-mediated synapsis. Here we
show that BRCA1 influences post-synaptic homologous recombination events, controlling the
balance between short- (STGC) and long-tract gene conversion (LTGC) between sister
chromatids. Brca1 mutant cells reveal a bias towards LTGC that is corrected by expression of wild
type but not cancer-predisposing BRCA1 alleles. The LTGC bias is enhanced by depletion of CtIP
but reversed by inhibition of 53BP1, implicating DNA end resection as a contributor to the STGC/
LTGC balance. The impact of BRCA1/CtIP loss on the STGC/LTGC balance is abolished when
the second (non-invading) end of the break is unable to support termination of STGC by
homologous pairing (“annealing”). This suggests that BRCA1/CtIP-mediated processing of the
second end of the break controls the annealing step that normally terminates SDSA, thereby
suppressing the error-prone LTGC outcome.
Introduction
Double-strand breaks (DSBs) are dangerous DNA lesions, the misrepair of which can
promote genomic instability and cancer 1,2. Chromosome breakage in proliferating cells
commonly arises in the S phase of the cell cycle during replication across a damaged DNA
template 3–5. Such DSBs can be repaired by sister chromatid recombination (SCR), a
potentially error-free pathway in which the broken chromosome uses the neighboring sister
chromatid as a template for repair by homologous recombination (HR). The major
hereditary breast/ovarian cancer predisposition genes, BRCA1 and BRCA2, have
established functions in HR. A long-standing hypothesis proposes that BRCA1 and BRCA2
execute tumor suppressor functions in sister chromatid recombination 6.
HR entails resection of the DNA end to single stranded (ss) DNA, on which Rad51
polymerizes to form a Rad51-ssDNA nucleoprotein filament 7–9. This filament conducts a
homology search by invading neighboring DNA duplexes and base-pairing with a
homologous donor such as the neighboring sister chromatid. A DNA polymerase extends the
invading 3’ DNA end (the “nascent” strand). In somatic eukaryotic cells, the major HR
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tpathway is “synthesis-dependent strand annealing” (SDSA), a non-crossover pathway in
which termination occurs by annealing of the displaced nascent strand with complementary
sequences in the resected second end of the broken chromosome 7. Gene conversion can
occur if the homologous donor differs in sequence from the broken chromosome.
Studies in yeast indicate the existence of at least two distinct copying mechanisms in HR,
which differ in their fidelity. In Saccharomyces cerevisiae, the majority of somatic gene
conversions entail SDSA-mediated copying of a short (< 200 bp) stretch of information from
the donor. An alternative pathway termed break-induced replication (BIR) can mediate long
gene conversions in yeast, potentially extending the nascent strand as far as the end of the
chromosome 10–13. BIR may entail formation of a bona fide replication fork at the site of
recombination and therefore requires both leading and lagging strand synthesis. In yeast,
BIR can arise in response to one-ended invasions occurring without a homologous second
end, a key trigger being the failure of the second end of the DSB to effect termination of
HR 14–17. To what extent BIR operates in mammalian cells is not well understood.
In mammalian cells, gene conversions typically extend less than 100 bp (“short tract” gene
conversion – STGC) 18–20. A small proportion of HR events entail “long tract” gene
conversion (LTGC), in which nascent strand synthesis extends several kilobases prior to
termination 21–23. LTGC is an error-prone HR outcome, causing tandem gene duplication
and, rarely, multi-copy gene amplification 22. Mammalian cells lacking any one of the
Rad51 paralogs XRCC3, Rad51C or XRCC2 reveal a specific defect in STGC and marked
bias in favor of LTGC, which accounts for ∼ 25% of all gene conversions in Rad51 paralog-
deficient cells 23–25. Increased proportions of LTGC-type products were also observed in a
Brca2 mutant hamster cell line and in Nbs1 null chicken DT40 lymphoblastoid cells 26,27.
The identity of other genes that regulate the balance between STGC and LTGC is unknown.
BRCA1 supports DNA end resection via its interactions with CtIP (C-terminus-binding
protein of adenovirus E1A-interacting protein) and the Mre11/Rad50/NBS1 (MRN)
complex to generate ssDNA that serves as substrate for BRCA2-mediated Rad51
nucleoprotein filament formation 28. BRCA1 also interacts with BRCA2 via the bridging
protein, PALB2 (partner and localizer of BRCA2), as well as with BACH1/BRIP1 and the
chromatin-associated RAP80 complex 29–32. Deletion of 53bp1, a gene implicated in NHEJ
and in the suppression of DNA end resection, rescues the Brca1 mutant phenotype in the
mouse, suggesting a primary role for BRCA1 in DNA end resection 33. Thus, the known
functions of BRCA1 in HR are restricted to early steps preceding Rad51-mediated synapsis.
To test whether BRCA1 influences later HR steps, we studied its contribution to STGC and
LTGC between sister chromatids, induced by a site-specific chromosomal DSB. We show
here that loss of BRCA1 or CtIP skews HR in favor of the LTGC outcome; this is reversed
by wild type BRCA1 but not by certain cancer-predisposing BRCA1 alleles. The influence
of BRCA1 and CtIP on the STGC/LTGC balance is lost when the second (non-invading)
end of the DSB is unable to support termination of STGC by annealing. We conclude that
BRCA1/CtIP controls the balance between STGC and LTGC by acting on the second end of
the DSB to support the annealing step that normally terminates STGC. These findings
suggest that a defect in early stages of HR, caused by loss of BRCA1 function, can translate
into a defect in HR termination, skewing this process towards error-prone repair at the
expense of error-free repair.
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A reporter for rapid flow cytometric analysis of LTGC
We previously described a SCR reporter to simultaneously measure STGC and LTGC
between sister chromatids 22,34. Expression of the rare-cutting homing endonuclease I-
SceI 35 induces a site-specific DSB within a mutant copy of the gene encoding enhanced
Green Fluorescent Protein (E-GFP, here termed “GFP”). Recombination between the broken
GFP copy and neighboring 5’ truncated GFP sequences produces wild type GFP by gene
conversion, and the cell changes from GFP– to GFP+. In the original reporter, duplication of
a cassette during LTGC enabled positive selection of LTGC through expression of a wild
type antibiotic resistance gene 22. We re-fashioned this reporter so that the cassette
duplicated during LTGC encodes the monomeric Red Fluorescent Protein RFP1.3 (here
termed “RFP”; Fig. 1A) 36. Briefly, we divided the RFP cDNA into two artificial exons
(“A” and “B” in Fig. 1A), with appropriate splice donor and acceptor sequences. The RFP
exons were placed “head to toe” between the two GFP copies of the reporter so that
transcription of exon A within the unmodified (“parental”) reporter will not lead to
expression of wild type RFP. During STGC, the cell becomes GFP+RFP– (Fig. 1A, outcome
#1). In contrast, LTGC typically generates three GFP copies (“GFP triplication”) by SCR
and duplicates the RFP cassette (Fig. 1A, outcome #2). Splicing between exon A of the first
cassette and exon B of the second generates wtRFP mRNA and the cell becomes
GFP+RFP+. A minority of LTGCs duplicate RFP exon B but terminate prior to triplication
of the GFP copies (“early termination” of LTGC—nascent strand extension of between 1252
bp and 3.4 kb).
We targeted a single copy of the RFP-SCR reporter to the ROSA26 locus of the mouse
embryonic stem (ES) cell line 11CO/47T 37, in which one Brca1 allele is truncated and the
second can be conditionally inactivated by Cre-mediated recombination (here termed
“Brca1fl/mut” cells, described in detail below; see Methods). Transfection of Brca1fl/mut
RFP-SCR reporter cells with I-SceI elicited GFP+RFP– and GFP+RFP+ products (Fig. 1B).
We used fluorescence activated cell sorting (FACS) to sort single GFP+RFP– or GFP+RFP+
cells from I-SceI-transfected samples, prepared genomic DNA (gDNA) from amplified
clones and analyzed the structure of the RFP-SCR reporter by Southern blotting. All FACS-
sorted GFP+RFP– clones revealed a structurally unrearranged RFP-SCR reporter, consistent
with STGC (examples in Fig. 1C, lanes G1-G3). In contrast, >95% of GFP+RFP+ clones
revealed rearrangements of the RFP-SCR reporter characteristic of LTGC (examples in Fig.
1C, lanes T1-T3; more detailed mapping in Supplementary Fig. S1).
Donor sister chromatid distinguishes LTGC from crossing over
The “GFP triplication” outcome could arise by either LTGC or crossing over. In LTGC, the
donor sister chromatid is unaltered, whereas crossing over results in loss of one GFP copy
from the donor sister (Fig. 1D). Previous work established that crossing over is suppressed
in somatic cells 21,23. To distinguish these mechanisms, we adapted a strategy we used
previously to capture the donor sister chromatid in the context of I-SceI-induced HR 23. We
found that a small fraction of sorted I-SceI-induced GFP+RFP+ cells were mixed colonies, in
which the GFP+RFP+ cell had been sorted subsequent to an LTGC event but prior to the
ensuing mitosis. Such clones should therefore contain HR products from both sister
chromatids. We identified four such mixed colonies; all (4/4) revealed the “GFP triplication”
outcome and an unrearranged donor (for example, lane T3 in Fig. 1D). Although the number
of events detected was small, the consistently unrearranged donor suggests that LTGC is the
major mechanism underlying the “GFP triplication” outcome.
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Figure 2A depicts the structure of the two Brca1 alleles in Brca1fl/mut ES cell line 11CO/
47T 37. One allele (“Brca1mut”) encodes a C-terminally truncated Brca1 gene product
(lacking a functional BRCT repeat). The second allele (“Brca1fl”) contains mouse Brca1
cDNA sequences corresponding to exons 22–24 flanked by loxP sites (Fig. 2A). Cre-
mediated deletion converts the functionally wt Brca1fl allele to a mutant allele (“Brca1Δ ”)
that encodes a C-terminally truncated Brca1 product similar to that encoded by the Brca1mut
allele. We transduced Brca1fl/mut RFP-SCR reporter ES cells with Cre-encoding adenovirus
and screened clones for Brca1 inactivation by real time qPCR (Fig. 2B and Methods). We
identified Brca1-deleted clones and others that remained undeleted. Brca1 null ES cells are
unviable 38; very likely, Brca1mut and Brca1Δ  are hypomorphic alleles. Consistent with this,
we detected by immunoblotting Brca1 gene products at low abundance in Brca1Δ /mut ES
cells clones. These Brca1 proteins were further depleted by siRNA directed to Brca1 (Fig.
2B).
To determine whether loss of wtBrca1 influences the balance between STGC and LTGC, we
transfected, in parallel, the above-noted Cre-treated Brca1fl/mut and Brca1Δ /mut RFP-SCR
reporter clones with either I-SceI plasmid or empty vector and quantified HR products (Fig.
2C; see Methods). In all experiments described here, clones that were treated with empty
vector control revealed typical background levels of ∼ 0.03% GFP+RFP– and of <0.001%
GFP+RFP+, with at least 200,000 events counted per sample. All I-SceI-induced HR
measurements were corrected for background events and for I-SceI transfection efficiency
(see Methods), the latter being typically between 65% and 85%; neither measurement varied
with Brca1 status. We compared four independent Cre-treated Brca1Δ /mut and Brca1fl/mut
RFP-SCR reporter clones. All four Brca1Δ /mut clones revealed reduced frequencies of HR,
as expected 39, but only a modest reduction in LTGC (Fig. 2C). The ratio: GFP+RFP+/Total
GFP+ estimates the probability that an I-SceI-induced GFP+ HR event will resolve as
LTGC. This probability was elevated ∼ 2-fold in Brca1Δ /mut cells in comparison with
isogenic Brca1fl/mut cells (Fig. 2C, lower panel). Thus, loss of wtBrca1 skews HR in favor
of LTGC.
We studied the structure of the reporter in I-SceI-induced GFP+RFP+ clones derived from
Brca1Δ /mut cells and isogenic Cre-treated Brca1fl/mut cells by Southern blotting. As noted
above, most LTGCs entail “GFP triplication” (Fig. 1A, outcome #2), while a minority
terminate within the reporter subsequent to duplication of RFP exon B (“early
termination”) 21–23,34. In Brca1fl/mut cells, 58/65 (89.2%) GFP+RFP+ clones entailed GFP
triplication while 4/65 (6.1%) GFP+RFP+ clones revealed early termination of LTGC. In
Brca1Δ /mut cells, 28/29 (96.6%) of GFP+RFP+ clones were GFP triplications and 1/29
(3.4%) revealed early termination of LTGC. Thus, loss of Brca1 does not grossly alter the
types of LTGC detected. Capture and analysis of the donor sister chromatid in mixed I-SceI-
induced GFP+RFP+ clones sorted from Brca1Δ /mut cells revealed an intact donor sister
chromatid in 3/3 GFP triplication clones examined, confirming that they arose by a non-
crossover mechanism, i.e., by LTGC.
Wild type BRCA1 rescues the HR defects of Brca1Δ/mut cells
The bias in favor of LTGC noted in Brca1Δ /mut cells could reflect secondary/compensatory
responses to Brca1 loss. To test this, we transiently co-transfected Brca1Δ /mut and, in
parallel, Brca1fl/mut RFP-SCR reporter clones with wt human BRCA1 and I-SceI and
measured HR. Human BRCA1 can restore normal development to Brca1 null mice 40.
Notably, wild type BRCA1 complemented the STGC defect and corrected the LTGC bias in
Brca1Δ /mut cells, but had little impact on any HR measurements in Brca1fl/mut cells (Fig. 3).
In contrast to wtBRCA1, expression of cancer-predisposing BRCA1 alleles encoding point
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BRCT repeat (P1749R, M1775R; Figs. 3D–3F) had no impact on HR in Brca1Δ /mut cells,
despite levels of BRCA1 mutant gene expression higher than those of wtBRCA1
(Supplementary Fig. S2; at the low levels of exogenous BRCA1 used in these experiments,
we were unable to detect the hBRCA1 protein). These results suggest that a tumor
suppressor function of BRCA1 specifically enforces STGC in favor of LTGC.
The above experiments implicate both the BRCA1 N-terminal RING and C-terminal BRCT
domains in STGC and in preventing an LTGC bias during HR. The BRCA1 RING domain
mediates constitutive heterodimerization with BARD1 in vertebrate cells and BRCA1 RING
domain mutations C61G and C64G disrupt the BRCA1-BARD1 interaction, while retaining
some residual function 41,42. We used transient transfection of siRNA to deplete either
Brca1 or Bard1 in Brca1Δ /mut or Brca1fl/mut RFP-SCR reporter cells in conjunction with I-
SceI transfection (see Methods). Consistent with the hypomorphic status of Brca1Δ /mut cells,
siRNA-mediated depletion of Brca1 reduced HR in both Brca1Δ /mut and Brca1fl/mut cells
(Supplementary Fig. S3). siRNA-mediated depletion of Brca1 also further exacerbated the
LTGC bias in Brca1Δ /mut cells, but produced only minimal alterations in the STGC/LTGC
balance in Brca1fl/mut cells. A similar pattern was observed following siRNA-mediated
depletion of Bard1 (Supplementary Fig. S3). The limited impact of Brca1-specific siRNA on
the STGC/LTGC balance in Brca1fl/mut cells may reflect residual activity of wtBrca1 in
siRNA-depleted Brca1fl/mut cells, and indicates that siRNA-mediated methods for perturbing
the LTGC/STGC balance have false negative rates, as was noted previously 23.
CtIP regulates the balance between STGC and LTGC
At least three major distinct DNA damage response complexes interact with the BRCA1/
BARD1 heterodimer via the BRCA1 tandem BRCT repeat, which they bind in a mutually
exclusive fashion. These are (direct BRCA1-interactors underlined): CCDC98/Abraxas,
RAP80, BRCC36, BRCC45, and MERIT40; BACH1 and TopBP1; and CtIP 29–31. These
interactions are disabled by BRCA1 BRCT mutations P1749R and M1775R. The failure of
these BRCA1 BRCT mutants to restore a normal STGC/LTGC balance to Brca1Δ /mut cells
therefore suggested possible roles for CtIP, BACH1 or Abraxas/Rap80 as regulators of the
STGC/LTGC balance. Bach1 depletion reduced HR in both Brca1Δ /mut and Brca1fl/mut
cells 43 (Supplementary Fig. S4). This suggests that at least part of Bach1’s HR function is
independent of its interaction with Brca1. Rap80 depletion caused an unexpected reduction
in HR in both Brca1Δ /mut and Brca1fl/mut cells, in contrast to recent findings of several
groups in cells with normal BRCA1 function 32,44,45. We do not understand the reason for
this difference; however, Rap80 depletion was found to reduce HR in one other study,
suggesting that Rap80’s function in HR is context-dependent 46. siRNA-mediated depletion
of CtIP, using either a single siRNA or SMARTpool siRNAs of non-overlapping specificity
with the single CtIP siRNA, reduced HR in both Brca1Δ /mut and Brca1fl/mut cells—
indicating that CtIP, like Bach1, can function in HR independent of its Brca1 interaction.
siRNA-mediated depletion of BACH1 or Rap80 revealed exactly proportional alterations in
I-SceI-induced STGC and LTGC in both Brca1Δ /mut and Brca1fl/mut cells (Supplementary
Fig. S4). In contrast, surprisingly, depletion of CtIP biased HR in favor of LTGC in both
Brca1Δ /mut and Brca1fl/mut cells (Figs. 4A – C).
CtIP regulates DNA end resection and is activated by the SIRT6 deacetylase 47. Notably,
Sirt6 depletion mimicked the effect of CtIP depletion, skewing HR in favor of LTGC, as did
depletion of Exo1, an exonuclease implicated in DNA end resection (Fig. 5 and
Supplementary Fig. S5); Inhibition of 53BP1—an antagonist of Brca1 DNA end resection
function 33—using a previously characterized dominant negative fragment of 53BP1 48,
specifically restored the STGC/LTGC balance to Brca1Δ /mut cells but did not affect this
balance in Brca1fl/mut cells (Fig. 5). This supports the idea that the LTGC bias in Brca1Δ /mut
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tcells is caused by a defect in DNA end resection. siRNA-mediated depletion of the early
DSB response protein Mre11 had no impact on the STGC/LTGC balance, suggesting that
not all resection proteins influence this balance (Supplementary Fig. S5). We considered the
possibility that the LTGC bias in ES cells depleted of CtIP might reflect altered cell cycle
distribution 49. However, cell cycle distribution did not vary between Brca1Δ /mut or
Brca1fl/mut cells, whether they received siRNA directed to Luciferase, Bard1 or CtIP
(Supplementary Fig. S6). We determined whether the LTGC bias in cells lacking BRCA1/
BARD1/CtIP is unique to mouse ES cells by studying human U2OS osteosarcoma cells
carrying a single integrated copy of the RFP-SCR reporter (see Methods). Consistent with
the above results, we observed a bias towards LTGC in U2OS cells depleted of BRCA1,
BARD1 or CtIP (Supplementary Fig. S7). Taken together, the results reveal a surprising and
specific role for BRCA1/BARD1, CtIP and certain other DNA end resection complexes in
controlling the balance between STGC and LTGC.
Brca1/CtIP controls the annealing step of SDSA
The idea that a defect in DNA end resection could translate into a defect in late stages of HR
seems paradoxical. We considered the hypothesis that the bias towards LTGC in Brca1
mutant cells is the consequence of failed termination of STGC. We tested this hypothesis by
constructing a new “one-ended” RFP-SCR reporter, in which the non-invading DNA end
(marked with a red star in Fig. 6A) lacks GFP sequences. I-SceI-induced STGC
(GFP+RFP–) occurring in this reporter cannot be terminated by homologous pairing
(annealing), but must instead use non-homologous mechanisms to rejoin the displaced
nascent strand with the non-invading, non-homologous second end of the DSB.
We targeted a single copy of the “one-ended” RFP-SCR reporter to the ROSA26 locus of
Brca1fl/mut ES cells. We generated isogenic clones of Cre-treated Brca1fl/mut one-ended
RFP-SCR reporter cells that either had or had not undergone deletion of wtBrca1. Consistent
with the longer gene conversion (332 bp) required to produce GFP+ products, we noted
∼ 10-fold lower frequencies of I-SceI-induced STGC (GFP+RFP+) products in Brca1fl/mut
cells compared to isogenic Brca1fl/mut cells containing a conventional “two-ended” RFP-
SCR reporter (Fig. 6B); in contrast, the absolute frequencies of I-SceI-induced LTGC were
little changed (Fig. 6B). Typically, about one third of all measured HR products were
GFP+RFP+, the remainder being GFP+RFP–; this varied from clone to clone, the maximum
LTGC:total HR ratio being ∼ 60%. Southern analysis of FACS-sorted I-SceI-induced
GFP+RFP– or GFP+RFP+ populations derived from either Brca1fl/mut or from Brca1Δ /mut
cells revealed STGC products of variable size, reflecting random termination by end joining
(Fig. 6C); LTGC products revealed a combination of “early terminating” LTGC (i.e., LTGC
with termination occurring between the two GFP copies of the donor) and “GFP
triplications” (Fig. 6C). Consistent with the absence of an annealing step that can reliably
terminate STGC, we noted a higher proportion of “early terminating” LTGCs in one-ended
reporter cells than in the original two-ended reporter cells: in Brca1fl/mut one-ended RFP-
SCR reporter cells, 6/21 (29%) of all LTGCs were early terminating and 15/21 (71%) were
GFP triplications; in Brca1Δ /mut one-ended RFP-SCR reporter cells, 9/23 (39%) of all
LTGCs were early terminating and 14/23 (61%) were GFP triplications (difference between
Brca1fl/mut and Brca1Δ /mutis not significant by x 2 analysis).
We noted reduced I-SceI-induced HR frequencies in four independent one-ended RFP-SCR
reporter Brca1Δ /mut clones, in comparison with four independent Brca1fl/mut clones (Fig.
7A). However, HR in Brca1Δ /mut one-ended RFP-SCR reporter cells revealed exactly
proportionate reductions in STGC and LTGC, with no additional LTGC bias (Fig. 7A).
Further, transient expression of wtBRCA1 in Brca1Δ /mut one-ended RFP-SCR reporter cells
restored both STGC and LTGC in equal proportions (Fig. 7B). Thus, in contrast to the
conventional two-ended RFP-SCR reporter (Fig. 3), in the context of the one-ended RFP-
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tSCR reporter, STGC and LTGC are each equivalently Brca1-dependent (Fig. 7B). Further,
siRNA-mediated depletion of CtIP reduced STGC and LTGC in equal proportions in both
Brca1fl/mut and Brca1Δ /mut one-ended RFP-SCR reporter cells and thus had no statistically
significant impact on the STGC/LTGC balance (Fig. 7C). Therefore, when the annealing
step of STGC is inactivated, loss of Brca1/CtIP has no impact on the relative balance
between STGC and LTGC.
Discussion
This report documents a functional communication between BRCA1 and later stages of HR,
as revealed by a bias towards LTGC when BRCA1 function is impaired. Expression of wild
type but not cancer-predisposing BRCA1 alleles restored the STGC/LTGC balance in Brca1
mutant cells, suggesting that BRCA1 performs a tumor suppressor function in this process.
Depletion of the BRCA1-interacting end resection protein CtIP (or its activator, Sirt6) or of
Exo1 mimicked or enhanced the Brca1 mutant STGC/LTGC imbalance. Further, inhibition
of 53BP1, a key antagonist of the DNA end resection function of Brca1, normalized the
STGC/LTGC balance in Brca1Δ /mut cells. This suggests that defects in DNA end processing
are the cause of the LTGC bias in Brca1Δ /mut cells. To identify mechanisms underlying this
phenomenon, we studied STGC and LTGC within a new “one-ended” reporter, in which
STGC cannot be terminated by annealing. Surprisingly, in the context of the “one-ended”
reporter, although overall HR retained dependence on BRCA1 and CtIP, loss of BRCA1/
CtIP no longer influenced the balance between STGC and LTGC. This suggests that
BRCA1/CtIP influences the STGC/LTGC balance in the context of two-ended DSBs by
facilitating the annealing step that normally terminates STGC—most likely, by ensuring
efficient and timely processing of the second end of the DSB (Fig. 8).
The SDSA model of somatic HR assumes an asymmetry between the two DNA ends, such
that one end undergoes Rad51-mediated strand exchange and the second end does not (Fig.
8) 7. How asymmetry is established during SDSA is unknown; it could be imposed at
several different stages, including the DNA end resection stage or during Rad51 filament
assembly. Although the model proposed in Fig. 8 envisions a direct role for Brca1, CtIP and
Exo1 in resection of the non-invading second end of the DSB, one or more of these proteins
might also coordinate communication between the two DNA ends during end resection.
Interestingly, Recent work in S. cerevisiae shows that the Mre11 nuclease and the CtIP
homolog, Sae2, provide coordinated resection of the two ends of radiation-induced DSBs 50.
Currently, however, it is not possible to measure second end resection or potential
asymmetry between the two DNA ends in mammalian cells. Interestingly, the failure of
Mre11 depletion to influence the STGC/LTGC balance suggests that not all mammalian
complexes implicated in DNA end resection affect the balance between STGC and LTGC.
In this regard, deletion of H2AX, an HR gene that can suppress DNA end resection in
certain contexts 51, does not appear to influence the STGC/LTGC balance 34.
Analyses of the impact of POL32 mutation on gap repair in S. cerevisiae 52 and in
Drosophila melanogaster 53 suggest that SDSA may entail several different mechanisms of
nascent strand extension that differ in their processivity and, hence, in their capacity to
mediate LTGC. A major alternative model proposes that mammalian LTGC is mediated by
a distinct copying mechanism, such as break-induced replication (BIR). BIR may entail
formation of a bona fide replication fork following strand exchange and therefore involves
lagging strand synthesis 11,15,54. A key trigger to BIR in yeast is a one-ended invasion
occurring without a homologous second end 10,11,14–17. In yeast, both RAD51-independent
and RAD51-dependent forms of BIR are recognized 7,11,14,15 13 RAD51-independent BIR
can act on short homologous sequences, tolerating homologies down to ∼ 30 bp 55. By
analogy, a defect in DNA end resection and Rad51 loading in Brca1 mutants might lead to
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tthe formation of abnormal synapses that favor BIR—perhaps similar to the recently
proposed idea of microhomology-mediated BIR (MM-BIR) 56—leading to the observed
LTGC bias in Brca1 mutants. We consider this BIR model of LTGC in detail below.
In contrast to the avid engagement of BIR following chromosomal one-ended invasions in S.
cerevisiae, the majority of chromsomal one-ended HR events in the mammalian system
studied here resolve as STGCs, as revealed by the abundance of GFP+RFP–products in this
setting. There is indeed a proportionate bias in favor of LTGC in the “one-ended” reporter
compared to the “two-ended” reporter; however, the absolute frequencies of I-SceI-induced
LTGC at the ROSA26 locus in Brca1fl/mut cells are equal in the two reporters (∼ 0.05%;
compare LTGC frequencies in Figs. 2C and 7A). Thus, a forced “one-ended” invasion in
mammalian cells does not preferentially trigger BIR. The major effect of a forced “one-
ended” invasion in our experiments is a ∼ 10-fold reduction in the frequency of GFP+RFP–
STGCs (compare STGC frequencies in Figs. 2C and 7A). Importantly, a gene conversion of
at least 331 bp is required to generate GFP+ recombinants within the “one-ended” reporter.
The Jasin and Nickoloff labs previously measured gene conversions (GCs) within a
conventional “two-ended” reporter in mammalian cells and observed that ∼ 80% of all GCs
are less than 58bp in length 19,20. This suggests that the majority of STGCs occuring within
the “one-ended” reporter studied here may have been terminated prior to conversion to
wtGFP and are therefore not detectable as GFP+ products. Our findings are consistent with
DNA fiber analysis of mammalian cells recovering from replication arrest, in which Rad51-
dependent HR repair of collapsed forks—presumably mediated by one-ended invasions—
was not found to be associated with replication restart 57.
Importantly, a pure 'replication fork' BIR model of LTGC also fails to explain why LTGC
should be relatively independent of BRCA1 in the “two-ended” reporter (Figs. 2 and 3), but
fully BRCA1-dependent in the context of the “one-ended” reporter (Figs. 7A and 7B). In
contrast, an SDSA model of LTGC can readily account for this difference, since it invokes a
defect of HR initiation in Brca1 mutant cells and, for the “two-ended” reporter only, a defect
of STGC termination by annealing (Fig. 8). These two defects will have opposing effects on
the absolute frequency of LTGC only in the context of the “two-ended” reporter and might
create the appearance that LTGC is BRCA1-independent in this setting (as in Fig. 3).
Notably, Rad51-mediated invasions can trigger BIR in Xenopus laevis egg extracts 58 and it
seems likely that a proportion of LTGCs in mammalian cells are bona fide BIR products.
However, definitive analysis must await the development of an assay in mammalian cells
that reliably separates BIR-mediated LTGCs from SDSA-mediated LTGCs.
A defect in annealing suggests a new mechanism underlying genomic instability associated
with loss of BRCA1. In BRCA1 mutant cells, a higher proportion of HR events may escape
the error-free annealing step of SDSA termination; these “functionally one-ended” invasions
will be obligatorily mutagenic. Thus, the BRCA1-dependent annealing step of SDSA
termination is likely an important bulwark against genomic instability and cancer.
Interestingly, a recent sequencing analysis of breast cancer genomes revealed elevated
frequencies of tandem gene segment duplications 59. Conceivably, some of these
rearrangements could be the result of inappropriate engagement of LTGC during DSB
repair.
Methods
Molecular biology and antibodies
The RFP-SCR reporter was constructed by conventional cloning methods using modified
ROSA26 targeting vectors 34. Expression vector for hBRCA1 was pcDNA3β  60. siRNA
SMARTpools were purchased from Dharmacon. Antibodies used were: Brca1 (Santa Cruz
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tand anti-human BRCA1 Ab MS110, 1:100), CtIP (Santacruz,1:50), Bard1 (Santacruz,
1:500), Mre11 (Novus, 1:6000), Sirt6 (Abcam, 1:500), Exo1 (Santacruz, 1:500), beta-actin
(Abcam, 1:2000) and influenza hemagglutinin epitope tag Ab (Santacruz, 1:1000). Cells
were lysed in RIPA buffer (50mM Tris-Hcl, pH 8.0, 250 mM NaCl, 0.1% sodium dodecyl
sulfate, 1% NP-40 with protease and phosphatase inhibitors. Extracted protein was resolved
by 4 −12 % bis-Tris SDS-PAGE (Invitrogen) and analyzed by Western blotting using the
antibodies described above. Supplementary Figs. S8 – S15 show full gel images of western
blots and of one Southern blot shown in other figures.
Cell Lines and Cell Culture
Brca1fl/mut ES cell line (11CO/47T) was a kind gift from Dr. Alan Ashworth 37. ES cells
were grown in ES medium on either MEF feeders or gelatinized plates. The RFP-SCR
reporter was targeted by electroporating 2 × 107 Brca1fl/mut ES cells with 20 µg of linearized
targeting vector, followed by seeding in 60 cm plates with puroR feeders. Puromycin (0.5
µg/ml) was added 24 hours later and colonies were picked 5–7 days later. Brca1fl/mut ES
cells contain one mutant Brca1 allele encoding a truncated gene product and a second Brca1
allele (which is functionally wild type but harbors loxP sites flanking exons 22–24) that can
be conditionally inactivated by Cre-mediated recombination. We generated multiple Brca1
deficient ES clones by transient adenovirus-mediated Cre expression to delete the exons 22–
24. Cell line U2OS was obtained from ATCC.
Southern Blotting
gDNA was extracted from confluent ES cells on 6-well plates (5–10 × 106 cells) using a
Puregene DNA Isolation Kit (Gentra Systems). Southern blotting was performed with GFP
cDNA or ROSA26 5’ probe. 7.5–10 µg of genomic DNA was digested with appropriate
restriction enzyme and run overnight on 0.8% gel with 0.5x TBE at 35V. The DNA was
transferred overnight onto nylon membrane in 1M NaCl, 0.4M NaOH. The membrane was
prehybridized for 30 minutes and labeled with GFP cDNA or ROSA26 5’ probe
overnight 34. The membrane was then washed and developed by autoradiography. In all
experiments, including U2OS cells containing a randomly integrated reporter, only clones
containing one intact copy of the reporter were used. Supplementary Fig. S8 – S15 show full
gel images of western blots and of one Southern blot shown in other figures.
Recombination Assays
2 × 105 cells were transfected in suspension in 24-well plates with 0.5 μ g pcDNA3β –myc
NLS-I-SceI 22 or 0.5 μ g control vector pcDNA3β  using Lipofectamine 2000 (Invitrogen).
GFP+ and GFP+RFP+ frequencies were measured 3 days post transfection by FACS using
Becton Dickinson 5 Laser LSRII in triplicates and corrected for transfection efficiency and
background events. (Transfection efficiency was measured simultaneously by parallel
transfection with 0.05 μ g wt GFP expression vector.) Typically ∼ 2 × 105 total events were
scored per sample. In the BRCA1 complementation experiments (Figure 3), rescue was
optimal at low levels of exogenous BRCA1 expression vector (0.1 μ g pcDNA3β –BRCA1 +
0.4 μ g pcDNA3β –myc NLS-I-SceI or control vector per well). For siRNA experiments, cells
were transfected with 1 μ l 20μ M (i.e., 20 pmol) siRNA + 0.3 μ g of pcDNA3β –myc NLS-I-
SceI (or control vector) per well. In Figures 3, 4, 5 and 6, HR data represents the mean and
standard error of the mean of three independent experiments. Statistical analysis was by
two-tailed paired t-test (unknown variance).
RT-qPCR analysis
RNA was extracted using QIAGEN RNeasy Mini Kit (QIAGEN Sciences, Maryland, MD).
Analysis of first-strand cDNA was by Power SYBR Green RNA-toCT™ 1-Step Kit
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t(Applied Biosystems, Foster City, CA). An ABI 7300 Real time PCR System was used for
RT-qPCR. Taqman probe and primer sets to genotype for Brca1 were: Brca1-Exon-22-23-
sense-TTC CGT GGT GAA GGA GCT T; Brca1-Exon-22-23-antisense-TGG CTG CAC
GAT CAC AAC; Brca1-Exon-23-24-sense-GCC TGG ACA GAA GAC AGC A; Brca1-
Exon-23-24-antisense-CAG TCC CAC ATC ACA AGA CG. We used conventional SYBR
green RT-qPCR assays of Gapdh and siRNA-targeted gene. We used Primer 3 software
(Whitehead Institute, MIT) to generate gene-specific primer sequences confirmed use of
each primer pair by melting curve analysis and gel electrophoresis. Primers for RT-PCR:
Human BRCA1-sense-TCA CAT GAT GGG GAG TCT GA; Human BRCA1-antisense-
TTC CCG ATA GGT TTT CCC AAA; Brca1-EXON21-22-sense-ATG AGC TGG AGA
GGA TGC TG; Brca1-EXON21-22-antisense-CTG GGC AGT TGC TGT CTT CT; Brca1-
EXON22-23-sense-GGT GCT CAT CTA GTT GTG ATC G; Brca1-EXON22-23-antisense-
CTG TAC CAG GTA GGC ATC CA; Brca1-EXON7-8-sense-AGC CTA GGT GTC CAG
CTG TC; Brca1-EXON7-8-antisense-CTG CAA TCA CCT GGC TTA GTT; CtIP-sense-
ATG GTC AAG AAT CTG AAC CC; CtIP-antisense-TGA GGA GGT GTC TTT GAA
GCA G; Bach1-sense-ATC CGG TGT CAG AGA TGT CC; Bach1-antisense-CAA GGA
GTA GAG CCC GTG AG; Rap80-sense-GAA GGA AAA CCC TCC TCC TG; Rap80-
antisense-TGT TCT TGG CCT CTC TTC GT. mRNA was measured in triplicates with a
standard curve generated for each gene using cDNA obtained from each sample. The
expression level of target genes was normalized to internal Gapdh.
Cell cycle analysis
ES cells were pulsed with 10 μ M BrdU for 15 minutes, 48 hours after transfection with
siRNA, and fixed in 70% ethanol. BrdU was counterstained using anti-BrdU (Boehringer-
Mannheim, 1:40) with a secondary FITC-conjugated rabbit anti-mouse antibody (Jackson
Immuno Research, 1:50). After exposure to RNase and staining with propidium diiodide,
approximately 104 events were acquired using a Becton Dickinson 5 Laser LSR II and the
results were analyzed using FloJo software.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. RFP-SCR reporter for quantifying short tract and long tract gene conversion
(A) Structure of the RFP-SCR reporter. Circles A and B: 5’ and 3’ artificial RFP exons.
Black arrows: promoters. Tr GFP: 5’ truncated GFP. Orange arrow: Rad51-mediated strand
invasion (3’ end marked with arrow head). Blue dashed arrow #1: short tract gene
conversion (STGC); #2: long tract gene conversion (LTGC). LTGC generates wtRFP
mRNA.
(B) I-SceI-induced HR products in Brca1fl/mut RFP-SCR reporter ES cells. Note GFP+RFP–
(STGC) and GFP+RFP+ (LTGC) populations.
(C) Southern blot analysis of HR products. “Parental”: unrearranged RFP-SCR reporter;
“GFP triplication”: LTGC or crossover product. B: Bgl II sites. Boxes are GFP copies; green
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tbox is wtGFP RFP cassette is not shown. Gel lanes - P: parental; G1-G3: GFP+RFP– STGC
products; T1-T3: GFP+RFP+ “GFP triplication” products.
(D) Donor sister chromatid structure distinguishes non-crossover (NCO) from crossover
(CO) “GFP triplication” outcome. Cartoon elements as in (C). Gel lanes - T1-T3:
GFP+RFP+ clones (different from panel C); P: parental. Note unrearranged donor sister in
T3, implying a NCO mechanism (LTGC).
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tFigure 2. Bias in favor of LTGC inBrca1Δ /mutES cells
(A) Brca1 gene structure in Brca1fl/mut ES cells. Brca1mut allele encodes truncated product.
Brca1fl allele converts to “Brca1Δ ” following Cre-mediated recombination. Grey boxes:
Brca1 exons; black triangles: loxP sites; SA: splice acceptor.
(B) Analysis of Brca1 gene products in Brca1fl/mut and Brca1Δ /mut ES cells. Left panel: RT
qPCR analysis of mRNA exon boundaries. Note loss of exon 22-23 signal in Brca1Δ /mut
cells. Right panel: Brca1 protein levels in Brca1fl/mut and Brca1Δ /mut ES cells following
transfection with siRNA against luciferase (si Luc) or Brca1 (si Brca1). Note persistent
Brca1 product in Brca1Δ /mut ES cells, consistent with hypomorphic status.
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t(C) I-SceI-induced HR in four independent Brca1fl/mut (blue diamonds) and four
independent Brca1Δ /mut (orange circles) Cre-treated RFP-SCR reporter ES cell clones. Each
point shows mean of quadruplicate samples for one independent clone. Error bars: standard
error of the mean (SEM) in this and all subsequent figures. STGC, LTGC and LTGC/Total
GC products shown. In last panel, error bars were smaller than symbols.
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tFigure 3. Wild type but not cancer predisposing mutant alleles of humanBRCA1complement the
STGC defect inBrca1Δ /mut ES cells
Data pooled from three independent experiments, each performed with triplicate samples.
Error bars: SEM, n=3.
(A) I-SceI-induced STGC in Brca1Δ /mut and Brca1fl/mut RFP-SCR reporter ES cells
transiently transfected with I-SceI and with either control (orange or blue), wtBRCA1
(maroon or dark blue), BRCA1 C61G (apricot or grey) or BRCA1 C64G (brown or teal).
Brca1Δ /mut cells: wtBRCA1 vs. control: paired t-test: P = 0.01. Other BRCA1 alleles vs.
control: Not Significant (NS). Brca1fl/mut cells: all test samples vs. control: NS.
(B) I-SceI-induced LTGC in experiment shown in (A). All test samples vs. control: NS.
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t(C) Ratio of I-SceI-induced LTGC/overall GC in experiment shown in (A) and (B).
Brca1Δ /mut cells: wtBRCA1 vs. control: paired t-test: P = 0.04. Other BRCA1 alleles vs.
control: NS. Brca1fl/mut cells: all test samples vs. control: NS.
(D) Similar to (A), but with BRCA1 P1749R (apricot or grey) or BRCA1 M1775R (brown
or teal). Brca1Δ /mut cells: wtBRCA1 vs. control: paired t-test: P = 0.05. Other BRCA1
alleles vs. control: NS. Brca1fl/mut cells: all test samples vs. control: NS.
(E) I-SceI-induced LTGC events in experiment shown in (D). All test samples vs. control:
NS.
(F) Ratio of I-SceI-induced LTGC/overall GC in experiment shown in (D) and (E).
Brca1Δ /mut cells: wtBRCA1 vs. control: paired t-test: P = 0.03. Other BRCA1 alleles vs.
control: NS. Brca1fl/mut cells: all test samples vs. control: NS.
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tFigure 4. CtIP controls the balance between LTGC and STGC
Data pooled from three independent experiments, each performed with triplicate samples.
Error bars: SEM, n=3.
(A) I-SceI-induced STGC in Brca1Δ /mut and Brca1fl/mut RFP-SCR reporter ES cells co-
transfected with I-SceI and with either control Luciferase siRNA (si Luc, orange or blue)
single CtIP siRNA (si CtIP, maroon or dark blue) or CtIP SMARTpool (si CtIP-smart,
apricot or grey). Paired t-test vs. si Luc in Brca1Δ /mut cells: si CtIP: P = 0.03; si CtIP-smart:
P = 0.03; in Brca1fl/mut cells: si CtIP: NS. si CtIP-smart: P = 0.05.
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t(B) I-SceI-induced LTGC in experiment shown in (A). Paired t-test vs. si Luc in Brca1Δ /mut
cells: si CtIP: P = 0.002; si CtIP-smart: P = 0.002; in Brca1fl/mut cells: si CtIP: NS. si CtIP-
smart: NS.
(C) Ratio of I-SceI-induced LTGC/overall GC in experiment shown in (A) and (B). Paired t-
test vs. si Luc in Brca1Δ /mut cells: si CtIP: P = 0.04; si CtIP-smart: P = 0.04; in Brca1fl/mut
cells: si CtIP: NS. si CtIP-smart: P = 0.01.
(D) Abundance of CtIP and actin (loading control) in siRNA-treated cells used in (A), (B)
and (C).
(E) RT qPCR analysis of CtIP mRNA in siRNA-treated cells used in panels (A), (B) and
(C).
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tFigure 5. Impact of overexpression of 53BP1 fragment and siRNA-mediated depletion of Exo1
on STGC and LTGC
Data pooled from three independent experiments, each performed with triplicate samples.
Error bars: SEM, n=3.
(A) I-SceI-induced STGC frequencies in Brca1Δ /mut and Brca1fl/mut RFP-SCR reporter ES
cells transiently co-transfected with I-SceI expression vector and with either control vector
(Control, orange or blue), F53BP1wt fragment (F53BP1wt, maroon or dark blue),
F53BP1D1521R fragment (D1521R, apricot or grey), Luciferase control siRNA (si Luc,
brown or teal) or SMARTpool siRNA against Exo1 (si Exo1, light brown or sky blue).
Paired t-test vs. control in Brca1Δ /mut cells: F53BP1wt: P = 0.0001: D1521R: NS; in
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tBrca1fl/mut cells: F53BP1wt: NS, D1521R: NS. Paired t-test si Luc vs. si Exo1 in Brca1Δ /mut
cells: P = 0.00007, in Brca1fl/mut cells: P = 0.0001. Error bars indicate SEM throughout.
(B) Frequency of I-SceI-induced LTGC events in the same experiment as panel (A). Paired
t-test vs. control in Brca1Δ /mut cells: F53BP1wt: NS: D1521R: NS; in Brca1fl/mut cells:
F53BP1wt: NS, D1521R: NS. Paired t-test si Luc vs. si Exo1 in Brca1Δ /mut cells: P = 0.001,
in Brca1fl/mut cells: P = 0.007.
(C) Ratio of I-SceI-induced GFP+RFP+/ total GFP+ frequencies (LTGC/ overall GC,
expressed as a percentage) from the same experiment as panels (A) and (B). Paired t-test
against control in Brca1Δ /mut cells: F53BP1wt: P = 0.0003, D1521R: NS; in Brca1fl/mut
cells: F53BP1wt: NS, D1521R: NS. Paired t-test si Luc vs. si Exo1 in Brca1Δ /mut cells: P =
0.0001, in Brca1fl/mut cells: P = 0.007.
(D) Abundance of 53BP1 fragments, Exo1 and actin (loading control) in treated Brca1Δ /mut
and Brca1fl/mut RFP-SCR reporter ES cells in (A), (B) and (C).
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tFigure 6. Analysis of I-SceI-induced STGC and LTGC in “one ended” HR reporter cells
(A) Structure of the “one-ended” RFP-SCR reporter. Circles A and B: 5’ and 3’ artificial
RFP exons. Tr GFP: 5’ truncated GFP. Black arrows: promoters. Orange arrow: Rad51-
mediated strand invasion (3’ end marked with arrow head). Second (non-invading) end of
DSB lacks GFP sequences (marked with red star; compare to Figure 1A). Annealing step is
not available to terminate STGC (GFP+RFP–) and STGC termination must occur by end
joining. LTGC (GFP+RFP+) products not shown.
(B) Primary FACS data showing I-SceI-induced HR products in Brca1fl/mut “one ended”
RFP-SCR reporter ES cells. Note I-SceI-induced GFP+RFP– (STGC) and GFP+RFP+
(LTGC) populations.
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t(C) Southern blot analysis of HR products in one-ended RFP-SCR reporter cells. “Parental”:
unrearranged reporter; “ET”: “Early termination” LTGC products. For “STGC/ET” events,
termination is predicted to occur by end-joining, producing HR products of varying size.
“GFP triplication”: LTGC product. B: Bgl II sites. I-SceI sites are marked, as are restriction
fragment sizes. Boxes are GFP copies; green box is wtGFP RFP cassette not shown. gDNA
from individual clones was digested in vitro with BglII alone or with BglII + I-SceI as
shown; Southern blot membranes were probed with GFP probe. The two left-hand panels
(Brca1fl/mut) are taken from one gel. The two right-hand panels (Brca1Δ /mut) are taken from
one gel. Gel lanes – P1-P2: parental clones; G1-G3: STGC (GFP+RFP–) clones; E1-E2:
early termination LTGC (GFP+RFP+) clones; T1-T2: LTGC (GFP+RFP+) “GFP
Triplication” clones. Only “parental” and “GFP triplication” clones contain an I-SceI site
within the repaired reporter; this site is lost in the STGC and ET clones. The slight
differences in gel mobility of the G1, G2, E1 and E2 bands between the two panels from the
Brca1fl/mut gel reflect bowing of the gel during electrophoresis or Southern transfer. Red
star: non-homologous second end of I-SceI-induced DSB.
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tFigure 7. BRCA1/CtIP fails to affect the STGC/LTGC balance if the annealing step of STGC
termination is abolished
(A) I-SceI-induced HR in four independent Cre-treated one-ended RFP-SCR reporter ES
cell clones of each genotype: Brca1fl/mut (blue diamonds) and Brca1Δ /mut (orange circles).
Each point shows mean of quadruplicate samples for one independent clone. Error bars:
standard error of the mean (SEM). If invisible, error bars were smaller than symbols.
(B) Wild type human BRCA1 complements both the STGC and LTGC defects in Brca1Δ /mut
one-ended RFP-SCR reporter ES cells. Data pooled from three independent experiments,
each performed in triplicate. Error bars: SEM, n=3.
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tTop panel: I-SceI induced STGC in Brca1Δ /mut and Brca1fl/mut one-ended RFP-SCR reporter
ES cells transiently transfected with I-SceI and with either control (orange or blue), or
wtBRCA1 (maroon or dark blue) expression vectors. Brca1Δ /mut cells: wtBRCA1 vs.
control: paired t-test: P = 0.003. Brca1fl/mut cells: wtBRCA1 vs. control: NS.
Middle panel: I-SceI-induced LTGC in experiment shown in top panel. Brca1Δ /mut cells:
wtBRCA1 vs. control: paired t-test: P = 0.003. Brca1fl/mut cells: wtBRCA1 vs. control: NS.
Bottom panel: Ratio of I-SceI-induced LTGC/overall GC in experiment shown in upper
panels. Brca1Δ /mut cells: wtBRCA1 vs. control: NS. Brca1fl/mut cells: wtBRCA1 vs. control:
NS.
(C) CtIP depletion reduces STGC and LTGC in equal proportions in one-ended RFP-SCR
reporter cells. Data pooled from three independent experiments, each performed with
triplicate samples. Left panel: I-SceI-induced STGC in Brca1Δ /mut and Brca1fl/mut RFP-SCR
reporter ES cells co-transfected with I-SceI and with either control Luciferase siRNA (si
Luc, orange or blue bars) or CtIP SMARTpool (si CtIP, maroon or dark blue bars). Paired t-
test in Brca1Δ /mut cells: paired t-test: P = 0.05; in Brca1fl/mut cells: paired t-test: P = 0.02.
Middle panel: I-SceI-induced LTGC in same experiment. Paired t-test Brca1Δ /mut cells: P =
0.04; in Brca1fl/mut cells: NS. Right panel: Ratio of I-SceI-induced LTGC/overall GC in
same experiment. Paired t-test in Brca1Δ /mut cells: NS; in Brca1fl/mut cells: NS.
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tFigure 8. Model: Brca1/CtIP acts on the second end of the DSB to promote the annealing step of
SDSA
(A) SDSA in wild type cells. Structural analysis of STGC in Figs. 1C and 6C suggest that
the homologous second end of the DSB normally “edits” short tract gene conversions to a
defined size.
(B) In cells lacking Brca1/CtIP function, defective DNA end resection and impaired
cooperation with Brca2/Rad51 results in a strand exchange defect. A defect in second end
resection leads to a relative impairment in the annealing step that normally terminates
STGC. As a result, a higher proportion of HR events escape termination as STGCs and
resolve as LTGCs. In the absence of a homologous second end of the DSB (such as in the
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t“one-ended” reporter—not shown in this figure), loss of Brca1/CtIP function has no impact
on STGC termination and does not affect the STGC/LTGC balance.
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